Care trajectory differences in women and men with end-stage renal disease after dialysis initiation.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 02 02 2023
accepted: 11 07 2023
medline: 18 9 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: epublish

Résumé

Few studies investigated sex-related differences in care consumption after dialysis initiation. Therefore, the aim of this study was to compare the care trajectory in the first year after dialysis start between men and women by taking into account the context of dialysis initiation. All patients who started dialysis in France in 2015 were included. Clinical data of patients and context of dialysis initiation were extracted from the Renal Epidemiology and Information Network (REIN) registry. Data on care consumption in the first year after dialysis start came from the French national health data system (SNDS): hospital stays <24h, hospital stays to prepare or maintain vascular access, hospital stays >24h for kidney problems and hospital stays >24h for other problems, and consultations with a general practitioner. Variables were compared between men and women with the χ2 test and Student's or Welch t-test and logistic regression models were used to identify the factors associated with care consumption after dialysis start. The analysis concerned 8,856 patients (36% of women). Men were less likely to have a hospital stays >24h for kidney problems than women (OR = 0.8, 95% CI = [0.7-0.9]) and less general practitioner consultations (OR = 0.8, 95% CI = [0.8-0.9]), in the year after dialysis initiation, after adjustment on patient's characteristics. Moreover, hospital stays for vascular access preparation or maintenance were longer in women than men (median duration: 2 days [0-2] vs. 1 day [0-2], p < 0.001). In conclusion, despite greater comorbidities in men, this study found few differences in post-dialysis care trajectory between men and women.

Identifiants

pubmed: 37708191
doi: 10.1371/journal.pone.0289134
pii: PONE-D-23-03003
pmc: PMC10501619
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289134

Informations de copyright

Copyright: © 2023 Piveteau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Mayo Clin Proc. 1984 Nov;59(11):769-75
pubmed: 6492872
J Am Soc Nephrol. 1995 May;5(11):1940-8
pubmed: 7620092
Am J Kidney Dis. 1999 May;33(5):927-33
pubmed: 10213651
Nephron. 2016;132(1):33-42
pubmed: 26588170
BMC Nephrol. 2018 Sep 17;19(1):233
pubmed: 30223784
Diabetes Care. 2007 Dec;30(12):3070-6
pubmed: 17848610
Nephrol Dial Transplant. 2006 Feb;21(2):411-8
pubmed: 16234286
Nat Rev Nephrol. 2018 Mar;14(3):151-164
pubmed: 29355169
Kidney Int. 2002 Jul;62(1):229-36
pubmed: 12081582
BMC Nephrol. 2020 Jan 28;21(1):25
pubmed: 31992233
J Am Soc Nephrol. 2017 Sep;28(9):2721-2728
pubmed: 28432127
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):178-182
pubmed: 30652978
Nephrol Ther. 2022 Jul;18(4):228-236
pubmed: 35773143
Nephrology (Carlton). 2016 Jan;21(1):62-7
pubmed: 26173588
Kidney Int. 2000 Jun;57(6):2557-63
pubmed: 10844625
Nephrol Ther. 2010 Dec;6(7):585-90
pubmed: 21075694
Am J Kidney Dis. 2003 Nov;42(5):972-81
pubmed: 14582041
Kidney Int Rep. 2020 Oct 31;6(1):156-167
pubmed: 33426395
Hemodial Int. 2011 Jan;15(1):23-9
pubmed: 21223483
Am J Kidney Dis. 2014 Nov;64(5):761-9
pubmed: 24927898

Auteurs

Juliette Piveteau (J)

EHESP, CNRS, Inserm, Arènes-UMR 6051, RSMS-U1309, Univ Rennes, Rennes, France.

Maxime Raffray (M)

EHESP, CNRS, Inserm, Arènes-UMR 6051, RSMS-U1309, Univ Rennes, Rennes, France.

Cécile Couchoud (C)

Renal Epidemiology and Information Network (REIN) Registry, Biomedecine Agency, Saint-Denis-La-Plaine, France.

Valérie Chatelet (V)

Centre Universitaire des Maladies Rénales, CHU Caen, Caen, France.
U1086 Inserm, ANTICIPE, Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Cécile Vigneau (C)

CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Univ Rennes, Rennes, France.

Sahar Bayat (S)

EHESP, CNRS, Inserm, Arènes-UMR 6051, RSMS-U1309, Univ Rennes, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH